Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
B1438 BMS-794833Target: MET|Flk-1Summary: Met/VEGFR-2 inhibitor,potent and ATP-competitive -
B1543 Mubritinib (TAK 165)Target: ErbBSummary: Potent inhibitor of HER2/ErbB2 -
B1544 Tyrphostin AG 879Summary: HER2 inhibitor -
B3383 DDR1-IN-1Summary: selective DDR1 receptor tyrosine kinase inhibitor -
N2031 PiceatannolSummary: p56lck/Syk inhibitor -
B6323 AG 99Summary: EGFR inhibitor -
B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: protein kinase inhibitor -
B6358 Methyl 2,5-dihydroxycinnamateSummary: EGF receptor-associated tyrosine kinases inhibitor -
B6360 Tyrphostin B44, (+) enantiomerSummary: EGFR-kinase inhibitor -
B6376 AG 556Summary: EGFR inhibitor

